Technology Commercialization Office

Showing 3 result(s) for "Oncology"



An improved delivery mechanism has been developed for camptothecin derivatives which will increase chemotherapeutic efficacy.

An efficient delivery vehicle for therapeutic oligonucleotides with high efficiency.

Nucleolin (NCL) is up-regulated in cancer cells, and modulates pro-tumorigenic pathways and chemoresistance. This anti-NCL agent binds and blocks NCL signaling, and may be optimized as cancer therapeutic and diagnostic tool.